-
Something wrong with this record ?
Safety of hydroimplantation: a foldable intraocular lens implantation without the use of an ophthalmic viscosurgical device
P. Studeny, M. Hyndrak, M. Kacerovsky, P. Mojzis, D. Sivekova, P. Kuchynka,
Language English Country Italy
Document type Comparative Study, Journal Article, Randomized Controlled Trial
PubMed
24846622
DOI
10.5301/ejo.5000491
Knihovny.cz E-resources
- MeSH
- Double-Blind Method MeSH
- Phacoemulsification methods MeSH
- Lens Implantation, Intraocular methods MeSH
- Middle Aged MeSH
- Humans MeSH
- Lenses, Intraocular * MeSH
- Intraocular Pressure physiology MeSH
- Intraoperative Complications MeSH
- Postoperative Complications MeSH
- Prospective Studies MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Tonometry, Ocular MeSH
- Corneal Endothelial Cell Loss pathology MeSH
- Viscosupplementation methods MeSH
- Viscosupplements administration & dosage MeSH
- Visual Acuity physiology MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Randomized Controlled Trial MeSH
- Comparative Study MeSH
PURPOSE: To compare the safety of a single-piece, foldable intraocular lens (IOL) hydroimplantation with that of a standard implantation using an ophthalmic viscosurgical device (OVD). METHODS: One hundred consecutive patients with bilateral age-related cataract surgery were enrolled into a prospective double-blind study. Each patient's first eye was randomly assigned to a standard implantation technique with an OVD or the hydroimplantation technique, while the fellow eye received the opposite technique. The main outcomes measured were endothelial cell loss, postoperative changes of intraocular pressure (IOP), and the frequency of complications. RESULTS: The reduction of endothelial cell density 1 month and 6 months after the surgery was 9.76% ± 13.5%, 10.7% ± 12.6%, respectively, in group A (OVD) and 9.07% ± 12.7%, 9.13% ± 13.7%, respectively, in group B (hydroimplantation). The differences were not statistically significant. The mean IOP 2 hours after surgery was 10.19 ± 6.78 mm Hg in group A and 9.92 ± 7.01 mm Hg in group B. Twenty-four hours and 1 month after surgery, the mean IOP was 14.52 ± 5.59 mm Hg and 13.21 ± 3.5 mm Hg, respectively, in group A, and 15.45 ± 5.77 mm Hg and 13.1 ± 3.44 mm Hg, respectively, in group B. The differences between groups A and B were not statistically significant. CONCLUSIONS: The hydroimplantation technique is a safe technique for single-piece foldable IOL implantation. There was no increase in intraoperative and postoperative complications compared with the standard implantation technique using an OVD.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15008047
- 003
- CZ-PrNML
- 005
- 20150324100736.0
- 007
- ta
- 008
- 150306s2014 it f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.5301/ejo.5000491 $2 doi
- 035 __
- $a (PubMed)24846622
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a it
- 100 1_
- $a Studeny, Pavel $u Eye Clinic Somich, Karlovy Vary - Czech Republic.
- 245 10
- $a Safety of hydroimplantation: a foldable intraocular lens implantation without the use of an ophthalmic viscosurgical device / $c P. Studeny, M. Hyndrak, M. Kacerovsky, P. Mojzis, D. Sivekova, P. Kuchynka,
- 520 9_
- $a PURPOSE: To compare the safety of a single-piece, foldable intraocular lens (IOL) hydroimplantation with that of a standard implantation using an ophthalmic viscosurgical device (OVD). METHODS: One hundred consecutive patients with bilateral age-related cataract surgery were enrolled into a prospective double-blind study. Each patient's first eye was randomly assigned to a standard implantation technique with an OVD or the hydroimplantation technique, while the fellow eye received the opposite technique. The main outcomes measured were endothelial cell loss, postoperative changes of intraocular pressure (IOP), and the frequency of complications. RESULTS: The reduction of endothelial cell density 1 month and 6 months after the surgery was 9.76% ± 13.5%, 10.7% ± 12.6%, respectively, in group A (OVD) and 9.07% ± 12.7%, 9.13% ± 13.7%, respectively, in group B (hydroimplantation). The differences were not statistically significant. The mean IOP 2 hours after surgery was 10.19 ± 6.78 mm Hg in group A and 9.92 ± 7.01 mm Hg in group B. Twenty-four hours and 1 month after surgery, the mean IOP was 14.52 ± 5.59 mm Hg and 13.21 ± 3.5 mm Hg, respectively, in group A, and 15.45 ± 5.77 mm Hg and 13.1 ± 3.44 mm Hg, respectively, in group B. The differences between groups A and B were not statistically significant. CONCLUSIONS: The hydroimplantation technique is a safe technique for single-piece foldable IOL implantation. There was no increase in intraoperative and postoperative complications compared with the standard implantation technique using an OVD.
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a úbytek endoteliálních buněk rohovky $x patologie $7 D055954
- 650 _2
- $a dvojitá slepá metoda $7 D004311
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a nitrooční tlak $x fyziologie $7 D007429
- 650 _2
- $a peroperační komplikace $7 D007431
- 650 _2
- $a implantace nitrooční čočky $x metody $7 D019654
- 650 12
- $a nitrooční čočky $7 D007910
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a fakoemulzifikace $x metody $7 D018918
- 650 _2
- $a pooperační komplikace $7 D011183
- 650 _2
- $a prospektivní studie $7 D011446
- 650 _2
- $a tonometrie oční $7 D014065
- 650 _2
- $a viskosuplementace $x metody $7 D055676
- 650 _2
- $a viskosuplementy $x aplikace a dávkování $7 D055675
- 650 _2
- $a zraková ostrost $x fyziologie $7 D014792
- 655 _2
- $a srovnávací studie $7 D003160
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a randomizované kontrolované studie $7 D016449
- 700 1_
- $a Hyndrak, Michal
- 700 1_
- $a Kacerovsky, Martin
- 700 1_
- $a Mojzis, Peter
- 700 1_
- $a Sivekova, Deli
- 700 1_
- $a Kuchynka, Pavel
- 773 0_
- $w MED00180219 $t European journal of ophthalmology $x 1724-6016 $g Roč. 24, č. 6 (2014), s. 850-6
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/24846622 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20150306 $b ABA008
- 991 __
- $a 20150324101024 $b ABA008
- 999 __
- $a ok $b bmc $g 1065320 $s 890847
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 24 $c 6 $d 850-6 $i 1724-6016 $m European journal of ophthalmology $n Eur J Ophthalmol $x MED00180219
- LZP __
- $a Pubmed-20150306